Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Doxycycline for COVID-19 (COVIVER-OUT PLUS)
NCT04729140Phase 4Unknown
- Sponsor
- Max Healthcare
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin, doxycycline in coronavirus disease 2019 (COVID-19), sponsored by Max Healthcare. Status: unknown.
02
Drugs
ivermectindoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04729140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729140.